home / stock / rare / rare articles

RARE Articles, Ultragenyx Pharmaceutical Inc.

Stock Information
Company Name: Ultragenyx Pharmaceutical Inc.
Stock Symbol: RARE
Market: NASDAQ
Website: ultragenyx.com
Menu
RARE RARE Quote RARE Short RARE News RARE Articles RARE Message Board
Get RARE Alerts

News, Short Squeeze, Breakout and More Instantly...
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results. AMMO reported a fourth-quarter profi...
Ultragenyx Posts New Data From Bone Disease Study | Benzinga

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), along with partner Mereo BioPharma (MREO), announced new positive 14-month data from the phase II po...

Dave & Buster's Posts Downbeat Results, Joins J.Jill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session | Benzinga

U.S. stock futures were mixed this morning, with the Dow futures falling around 100 points on Thursday. Shares of Dave & Buster’s Enterta...

This United Airlines Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrade...
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

NOVATO, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the devel...

Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells | Benzinga

The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical (NASDAQ:RARE) over the use of c...

Ultragenyx to Participate at Bank of America's 2024 Healthcare Conference | Benzinga

NOVATO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the develo...
Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update | Benzinga

NOVATO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the deve...

S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March | Benzinga

U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0.64% to 37,741.18 whi...

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...
Next 10